Commission acts on CHMP Esmya advice

The European Commission has “opened the way” for Gedeon Richter to relaunch in European markets the Esmya (ulipristal acetate) women’s healthcare brand, after adopting an opinion from the CHMP recommending measures to minimise the risk of rare but serious liver injury.